Finding studies
Finding studies
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of 3-AP in treating patients who have advanced prostate cancer that has been previously treated with hormone therapy.
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Vion Pharmaceuticals
OBJECTIVES: * Determine the response rate in patients with advanced hormone-refractory prostate cancer treated with 3-AP. * Determine the toxic effects of this drug in these patients. OUTLINE: This is a multicenter study. Patients receive 3-AP IV over 2 hours on days 1-4. Treatment repeats every 2 weeks for up to 1 year in the absence of disease progression or unacceptable toxicity. Patients are followed every 2-3 months for up to 1 year. PROJECTED ACCRUAL: Approximately 13-27 patients will be accrued for this study.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
